Dermatology · PANCE / PANRE

Impetigo

Superficial bacterial skin infection (S. aureus or S. pyogenes) producing honey-colored crusted erosions; highly contagious in children.

Also known as: impetigo, non-bullous impetigo, bullous impetigo, ecthyma

Overview

Highly contagious superficial bacterial skin infection caused predominantly by Staphylococcus aureus and Streptococcus pyogenes. Classified as non-bullous (most common), bullous, or ecthyma (ulcerative deeper variant).

Epidemiology

Most common bacterial skin infection in children ages 2-5; peak incidence in summer/fall. Affects ~140 million people globally. Bullous impetigo predominantly in neonates and young children. Higher rates in crowded conditions, hot/humid climates, and individuals with atopic dermatitis.

Try two board-style Impetigo questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1DermatologyEasy
A 4-year-old boy who attends daycare is brought in with several lesions around the mouth and nares that began as small vesicles and have evolved into golden, honey-colored crusts. He is afebrile and otherwise well, and the lesions are mildly itchy but not painful. Which of the following is the most likely diagnosis?
  • AContact dermatitis
  • BImpetigo
  • CHerpes simplex virus infection
  • DAtopic dermatitis
Reveal answer & full explanation
Correct answer: B — Impetigo
  • AContact dermatitis
  • BImpetigo
  • CHerpes simplex virus infection
  • DAtopic dermatitis

Why Impetigo is correct

  • Non-bullous impetigo is the most common bacterial skin infection in young children and spreads readily in daycare settings
  • The hallmark is golden, honey-colored crusting that develops from initial vesicles, classically around the mouth and nares
  • Staphylococcus aureus is the leading cause, followed by group A Streptococcus
  • The well, afebrile child with superficial perioral crusts fits a localized superficial pyoderma rather than a systemic or chronic process

Why the others are wrong

  • Contact dermatitis — produces erythema, edema, and vesicles in the distribution of an external allergen and does not form honey-colored crust (anchoring on the initial vesicles)
  • Herpes simplex virus infection — causes grouped vesicles on an erythematous base that ulcerate and are painful, without the characteristic honey crust (buzzword-matching the word "vesicles")
  • Atopic dermatitis — a chronic, intensely pruritic eczematous condition favoring flexural skin, not an acute perioral crusted eruption (premature closure on a common pediatric rash)
Question 2DermatologyEasy
A 6-year-old boy presents with a honey-crusted, golden-yellow lesion on his nose and around his mouth. His 3-year-old sibling developed similar lesions. He has no fever. What is the most likely diagnosis?
  • AHerpes labialis
  • BPerioral dermatitis
  • CContact dermatitis
  • DImpetigo
Reveal answer & full explanation
Correct answer: D — Impetigo
  • AHerpes labialis
  • BPerioral dermatitis
  • CContact dermatitis
  • DImpetigo

Why impetigo is correct

  • Impetigo is the most common bacterial skin infection in children
  • Caused by S. aureus (most common) or S. pyogenes
  • Non-bullous (crusted) form presents with honey-colored crusts on the face around the mouth and nose
  • Highly contagious, explaining sibling spread

Why the others are wrong

  • A) Herpes labialis — shows grouped vesicles on an erythematous base, not honey-colored crusts
  • B) Perioral dermatitis — papulopustules that spare the vermilion border, typically after topical steroid use, not honey-colored crusts
  • C) Contact dermatitis — pruritic, sharply demarcated erythema and vesicles limited to the site of allergen or irritant contact, with no crusting

Additional high-yield points

  • Treatment for localized disease: mupirocin 2% ointment three times daily (TID) x 5 days
  • Oral antibiotics (cephalexin or dicloxacillin) used for widespread, bullous, or recurrent disease
  • MRSA coverage with trimethoprim-sulfamethoxazole (TMP-SMX) or doxycycline if MRSA is suspected
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Impetigo outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Disrupted skin barrier — atopic dermatitis, scabies, insect bites, abrasions, varicella
  • Crowded living, daycare, sports involving skin contact (wrestling, football)
  • Hot humid climates, poor hygiene
  • Diabetes, immunosuppression
  • Nasal carriage of S. aureus (especially MRSA)

Pathophysiology

Non-bullous impetigo: bacteria invade skin through breaks in barrier, producing intraepidermal pustules that rupture and crust. Bullous impetigo: S. aureus phage group II produces exfoliative toxin (ET-A) that cleaves desmoglein-1 in the granular layer → flaccid bullae. Ecthyma: deeper dermal invasion → ulcerative crusted lesion that heals with scar.

Clinical presentation

Symptoms

  • Minimal systemic symptoms; rarely fever (unless extensive)
  • Local pruritus, mild discomfort
  • Lesions noticed by parents or coaches

Signs / physical exam

  • Non-bullous: thin-walled vesicle/pustule on erythematous base → rapidly ruptures → erosion with honey-colored (yellow-brown) crust; face (perioral, perinasal), extremities; well-demarcated; minimal surrounding inflammation
  • Bullous: flaccid clear/cloudy bullae 1-5 cm on intact skin (no erythematous base required) that rupture leaving collarette of scale and varnish-like brown crust; trunk, extremities, intertriginous areas; neonates and young children
  • Ecthyma: punched-out ulcer with adherent yellow-gray crust and surrounding violaceous halo; lower extremities; heals with scarring
  • Regional lymphadenopathy in 90% of non-bullous cases

Classic findings

Honey-colored crust on superficial erosions in a child; flaccid bullae with brown varnish-like crusts (bullous form).

Differential diagnosis

  • Herpes simplex (HSV) — Grouped vesicles on erythematous base, prodromal tingling, recurrent in same site; Tzanck/PCR positive
  • Varicella — Generalized eruption in different stages, fever, vesicles on erythematous base ('dew drop on rose petal')
  • Contact dermatitis with secondary infection — Pattern matches exposure; pruritus predominant before crusting
  • Tinea corporis with secondary infection — Annular plaque with peripheral scale; KOH positive
  • Pemphigus / pemphigoid (bullous DDx) — Older adult, widespread bullae, painful mucosae (pemphigus); DIF positive
  • Stevens-Johnson syndrome (bullous DDx) — Mucosal involvement, drug exposure, systemic symptoms
  • Staphylococcal scalded skin syndrome (SSSS) — Diffuse erythema and superficial desquamation; positive Nikolsky; fever; young child
  • Ecthyma gangrenosum (vs ecthyma) — Necrotic ulcer with black eschar in neutropenic patient; Pseudomonas bacteremia

Diagnostic workup

Diagnostic criteria

Clinical: characteristic honey-colored crusted lesions or flaccid bullae in a typical patient; culture confirms organism and susceptibility.

Labs

  • Clinical diagnosis usually sufficient
  • Gram stain and culture of exudate (especially in suspected MRSA, treatment failure, severe disease, outbreaks)
  • Anti-DNase B and anti-streptolysin O titers (rising in post-streptococcal glomerulonephritis surveillance — not routine)
  • Urinalysis 1-3 weeks after streptococcal impetigo if PSGN suspected (hematuria, edema, HTN)

Imaging

  • Not indicated

Diagnostic algorithm

VariantHallmarkTherapy
Non-bullousHoney-colored crusts on face/extremitiesTopical mupirocin × 5 d (limited); oral cephalexin/dicloxacillin × 7 d (extensive)
BullousFlaccid bullae → varnish-like brown crust (toxin-mediated)Oral cephalexin/dicloxacillin; admit neonates
EcthymaPunched-out ulcer with adherent crust, scars on healingOral antibiotics × 7-10 d; local wound care
MRSA-suspectedTreatment failure, purulent, abscessClindamycin, TMP-SMX, or doxycycline based on susceptibilities
Impetigo variants and antimicrobial selection.

Treatment

First-line

  • Limited (≤5 lesions, small body area, non-bullous): topical mupirocin 2% ointment TID × 5 days OR topical retapamulin 1% ointment BID × 5 days OR topical ozenoxacin 1% cream BID × 5 days
  • Extensive, bullous, ecthyma, or treatment failure (systemic antibiotics × 7 days): cephalexin 25-50 mg/kg/day divided QID (pediatric) or 250-500 mg QID (adult); dicloxacillin 12.5 mg/kg/day pediatric or 250-500 mg QID adult — covers MSSA and S. pyogenes
  • Penicillin-allergic (non-anaphylactic): cephalexin acceptable; (anaphylactic): clindamycin 10-30 mg/kg/day pediatric or 300-450 mg QID adult, or doxycycline (≥8 years)
  • MRSA suspected: clindamycin (check D-test for inducible resistance), trimethoprim-sulfamethoxazole, doxycycline, linezolid; mupirocin remains effective for many MRSA strains
  • Hygiene: hand washing, nail trimming, separate towels and bedding, cover lesions; school exclusion until 24 hours of antibiotics or lesions crusted over
  • Decolonization for recurrent: intranasal mupirocin BID × 5 days + chlorhexidine washes + household decontamination

Bullous impetigo (neonates)

  • Low threshold for hospital admission, IV antibiotics (nafcillin, oxacillin, vancomycin if MRSA risk)
  • Differentiate from staphylococcal scalded skin syndrome which requires broader management

Ecthyma

  • Systemic antibiotics (as above) × 7-10 days
  • Local wound care with gentle debridement
  • Counsel: heals with scarring (unlike standard impetigo)

Second-line / adjunct

  • Mupirocin resistance documented in some regions — fusidic acid or retapamulin are alternatives
  • Bleach baths for recurrent disease in atopic dermatitis patients
  • Treat underlying skin disease (scabies, eczema)

Complications

  • Cellulitis, lymphangitis, bacteremia
  • Post-streptococcal glomerulonephritis (PSGN) — 1-5% incidence after streptococcal skin infection, 1-3 weeks post-infection; antibiotic treatment does NOT prevent PSGN once infection established
  • Acute rheumatic fever is NOT a complication of streptococcal impetigo (unlike pharyngitis)
  • Staphylococcal scalded skin syndrome (SSSS) from toxin spread
  • Scarlet fever
  • Permanent scarring from ecthyma
  • Recurrence with persistent nasal/skin S. aureus colonization

PANCE pearls

  • Honey-colored crust on a child's face = impetigo. Topical mupirocin × 5 days is sufficient for limited disease.
  • Bullous impetigo is caused by S. aureus exfoliative toxin (same family that produces SSSS); the bullae are typically on intact-appearing skin without erythematous halo.
  • Antibiotic treatment of streptococcal impetigo does NOT prevent post-streptococcal glomerulonephritis once infection is established — but does prevent transmission and other complications.
  • Recurrent impetigo warrants S. aureus decolonization (intranasal mupirocin + chlorhexidine).
  • Ecthyma heals with scarring; standard impetigo does not.

References

  • IDSA 2014 — Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America (Stevens et al., Clin Infect Dis 2014)
  • AAP Red Book 2024 — American Academy of Pediatrics Red Book — Staphylococcal and Streptococcal Skin Infections (2024 update)
  • AAFP 2014 — Impetigo: Diagnosis and Treatment (Hartman-Adams, Banvard, Juckett, Am Fam Physician 2014)

Practice Dermatology questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.